{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:54:21Z","timestamp":1785218061936,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","meddos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Dosimetry"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.meddos.2022.03.001","type":"journal-article","created":{"date-parts":[[2022,4,12]],"date-time":"2022-04-12T17:27:47Z","timestamp":1649784467000},"page":"222-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tubarial salivary gland sparing with proton therapy"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-0509","authenticated-orcid":false,"given":"Christopher M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-9342","authenticated-orcid":false,"given":"Daniel Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1100-1298","authenticated-orcid":false,"given":"Michele","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-3000","authenticated-orcid":false,"given":"Andrew R.","family":"Barsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4382-5187","authenticated-orcid":false,"given":"Boon-Keng Kevin","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Lukens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Swisher-McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1254-8324","authenticated-orcid":false,"given":"Alexander","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meddos.2022.03.001_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.meddos.2022.03.001_bib0002","doi-asserted-by":"crossref","first-page":"724","DOI":"10.15585\/mmwr.mm6833a3","article-title":"Human papillomavirus\u2013attributable cancers \u2014 United States, 2012\u20132016","volume":"68","author":"Senkomago","year":"2019","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.meddos.2022.03.001_bib0003","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jnci\/92.9.709","article-title":"Evidence for a causal association between human papillomavirus and a subset of head and neck cancers","volume":"92","author":"Gillison","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.meddos.2022.03.001_bib0004","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.meddos.2022.03.001_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","article-title":"Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): A randomised, multicentre, non-inferiority trial","volume":"393","author":"Gillison","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.meddos.2022.03.001_bib0006","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1158\/0008-5472.CAN-13-0587","article-title":"Enhanced radiation sensitivity in HPV-positive head and neck cancer","volume":"73","author":"Kimple","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.meddos.2022.03.001_bib0007","doi-asserted-by":"crossref","first-page":"873","DOI":"10.6004\/jnccn.2020.0031","article-title":"Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Pfister","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.meddos.2022.03.001_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.meddos.2022.03.001_bib0009","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0010","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.radonc.2015.01.019","article-title":"Acute symptoms during the course of head and neck radiotherapy or chemoradiation are strong predictors of late dysphagia","volume":"115","author":"Van Der Laan","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0011","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ijrobp.2010.05.012","article-title":"Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer","volume":"79","author":"Van De Water","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.meddos.2022.03.001_bib0012","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.ijrobp.2016.02.044","article-title":"Intensity modulated proton therapy versus intensity modulated photon radiation therapy for oropharyngeal cancer: first comparative results of patient-reported outcomes","volume":"95","author":"Sio","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.meddos.2022.03.001_bib0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.radonc.2016.05.022","article-title":"Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer \u2013 A case matched analysis","volume":"120","author":"Blanchard","year":"2016","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0014","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.meddos.2016.01.002","article-title":"Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis","volume":"41","author":"Holliday","year":"2016","journal-title":"Med. Dosim."},{"key":"10.1016\/j.meddos.2022.03.001_bib0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/0284186X.2012.692885","article-title":"The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study","volume":"52","author":"Van Der Laan","year":"2013","journal-title":"Acta Oncol. (Madr)."},{"key":"10.1016\/j.meddos.2022.03.001_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00032.1","article-title":"Quality of life of postoperative photon versus proton radiation therapy for oropharynx cancer","volume":"5","author":"Sharma","year":"2019","journal-title":"Int. J. Part. Ther."},{"key":"10.1016\/j.meddos.2022.03.001_bib0017","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00405-010-1460-3","article-title":"Non-neoplastic salivary gland lesions: A 15-year study","volume":"268","author":"Mohan","year":"2011","journal-title":"Eur. Arch. Oto-Rhino-Laryngology"},{"key":"10.1016\/j.meddos.2022.03.001_bib0018","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1288\/00005537-197706000-00016","article-title":"Mucous glands in the developing human rhinopharynx","volume":"87","author":"Tos","year":"1977","journal-title":"Laryngoscope"},{"key":"10.1016\/j.meddos.2022.03.001_bib0019","first-page":"1","article-title":"Anatomy, biogenesis and regeneration of salivary glands","author":"Holmberg","year":"2014","journal-title":"Monogr. Oral Sci."},{"key":"10.1016\/j.meddos.2022.03.001_bib0020","series-title":"StatPearls","article-title":"Anatomy, Head and Neck, Salivary Glands. 2021 Jun 11","author":"Ghannam","year":"2021"},{"key":"10.1016\/j.meddos.2022.03.001_bib0021","article-title":"The tubarial salivary glands: A potential new organ at risk for radiotherapy","author":"Valstar","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"key":"10.1016\/j.meddos.2022.03.001_bib0023","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0024","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.oraloncology.2018.08.011","article-title":"Target delineation for postoperative treatment of head and neck cancer","volume":"86","author":"Evans","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.meddos.2022.03.001_bib0025","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2019.08.038","article-title":"NRG-HN002: A randomized phase II trial for patients with p16-positive, non-smoking-associated, locoregionally advanced oropharyngeal cancer","volume":"105","author":"Yom","year":"2019","journal-title":"Int. J. Radiat. Oncol."},{"key":"10.1016\/j.meddos.2022.03.001_bib0026","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semradonc.2008.09.008","article-title":"Balancing risk and reward in target delineation for highly conformal radiotherapy in head and neck cancer","author":"Eisbruch","year":"2009","journal-title":"Semin. Radiat. Oncol."},{"issue":"Suppl. 3","key":"10.1016\/j.meddos.2022.03.001_bib0027","first-page":"76","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues","volume":"S3","author":"Bentzen","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"Suppl. 3","key":"10.1016\/j.meddos.2022.03.001_bib0028","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2009.06.090","article-title":"Radiotherapy dose-volume effects on salivary gland function","volume":"76","author":"Deasy","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."}],"container-title":["Medical Dosimetry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394722000243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958394722000243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:32:52Z","timestamp":1760693572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958394722000243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S0958394722000243"],"URL":"https:\/\/doi.org\/10.1016\/j.meddos.2022.03.001","relation":{},"ISSN":["0958-3947"],"issn-type":[{"value":"0958-3947","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tubarial salivary gland sparing with proton therapy","name":"articletitle","label":"Article Title"},{"value":"Medical Dosimetry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meddos.2022.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}